Lv1
40 积分 2025-09-28 加入
The immunohistology of IgA nephropathy
1天前
待确认
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
22天前
已完结
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
24天前
已完结
Efficacy and safety of budesonide for the treatment of IgA nephropathy: a systematic review and meta-analysis
24天前
已完结
Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality
1个月前
已关闭
Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality: Target Trial Emulation Studies
1个月前
已完结
Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality: Target Trial Emulation Studies
1个月前
已完结
Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
1个月前
已完结
Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy
1个月前
已关闭
Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy
1个月前
已完结
皖公网安备34019202002308
